McIlrath & Eck’s Novo Nordisk NVO Stock Holding History

McIlrath & Eck’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.35K	Hold	200	–	–	﹤0.01%	1126
2025 Q4	$10.2K	Hold	200	–	–	﹤0.01%	650
2025 Q3	$11.1K	Hold	200	–	–	﹤0.01%	608
2025 Q2	$13.8K	Hold	200	–	–	﹤0.01%	547
2025 Q1	$13.9K	Hold	200	–	–	﹤0.01%	549
2024 Q4	$17.2K	Hold	200	–	–	﹤0.01%	509
2024 Q3	$23.8K	Hold	200	–	–	﹤0.01%	442
2024 Q2	$28.5K	Sell	200 -505	-72%	-$66.9K	﹤0.01%	372
2024 Q1	$90.5K	Buy	+705	New	+$83.9K	0.01%	190
2023 Q2	–	Sell	-26	Closed	-$2.07K	–	926
2023 Q1	$2.07K	Buy	+26	New	+$1.84K	﹤0.01%	773
2021 Q3	–	Sell	-674	Closed	-$28K	–	819
2021 Q2	$28K	Hold	674	–	–	0.01%	329
2021 Q1	$23K	Hold	674	–	–	0.01%	319
2020 Q4	$24K	Hold	674	–	–	0.01%	274
2020 Q3	$23K	Hold	674	–	–	0.01%	241
2020 Q2	$22K	Hold	674	–	–	0.01%	225
2020 Q1	$20K	Hold	674	–	–	0.01%	189
2019 Q4	$20K	Hold	674	–	–	0.01%	240
2019 Q3	$17K	Hold	674	–	–	0.01%	246
2019 Q2	$18K	Hold	674	–	–	0.01%	215
2019 Q1	$18K	Buy	+674	New	+$16.6K	0.01%	215
2018 Q3	–	Sell	-1,602	Closed	-$37K	–	562
2018 Q2	$37K	Hold	1,602	–	–	0.02%	135
2018 Q1	$39K	Buy	1,602 +2	+0.1%	+$53	0.02%	139
2017 Q4	$43K	Buy	+1,600	New	+$40.7K	0.03%	139

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

McIlrath & Eck's NVO Position: Q1 2026 in Review

McIlrath & Eck held its Novo Nordisk (NVO) position steady in Q1 2026 at 200 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

McIlrath & Eck first reported a position in NVO in Q4 2017 and has held it in 23 quarters since. The position peaked at $90.5K in Q1 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

McIlrath & Eck held 200 shares of Novo Nordisk worth $7.35K as of Q1 2026.
McIlrath & Eck left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1126 holding.
McIlrath & Eck first reported a position in Novo Nordisk in Q4 2017 and has held it in 23 quarters since.
McIlrath & Eck's Novo Nordisk position peaked at $90.5K in Q1 2024.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.